Systematic Review

Published on 29 May 2019

The Efficacy of Different Chemotherapy Regimens for Advanced Biliary Tract Cancer: A Systematic Review and Network Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Yan Li
Yaoyao Zhou
Yonglan Hong
Meizhi He
Shuyi Wei
Chen Yang
Dayong Zheng
Feiye Liu

Frontiers in Oncology

doi 10.3389/fonc.2019.00441

6,994 views
7 citations

Case Report

Published on 22 May 2019

Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia

in Pharmacology of Anti-Cancer Drugs

Nils W. Engel
Simon Schliffke
Ulrich Schüller
Christian Frenzel
Carsten Bokemeyer
Christian Kubisch
Davor Lessel

Frontiers in Oncology

doi 10.3389/fonc.2019.00420

4,318 views
16 citations

Original Research

Published on 17 May 2019

Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas

in Pharmacology of Anti-Cancer Drugs

Cun Liu
Huayao Li
Kejia Wang
Jing Zhuang
Fuhao Chu
Chundi Gao
Lijuan Liu
Fubin Feng
Chao Zhou
Wenfeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2019.00368

7,865 views
34 citations

Original Research

Published on 14 May 2019

Triptolide Induces Glioma Cell Autophagy and Apoptosis via Upregulating the ROS/JNK and Downregulating the Akt/mTOR Signaling Pathways

in Pharmacology of Anti-Cancer Drugs

Xihong Liu
Peiyuan Zhao
Xiujuan Wang
Lei Wang
Yingjun Zhu
Wei Gao

Frontiers in Oncology

doi 10.3389/fonc.2019.00387

6,381 views
45 citations

Review

Published on 09 May 2019

Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells

in Pharmacology of Anti-Cancer Drugs

Gianluca Civenni
Domenico Albino
Dheeraj Shinde
Ramiro Vázquez
Jessica Merulla
Aleksandra Kokanovic
Sarah N. Mapelli
Giuseppina M. Carbone
Carlo V. Catapano

Frontiers in Oncology

doi 10.3389/fonc.2019.00385

7,263 views
13 citations

Original Research

Published on 09 May 2019

Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis

in Pharmacology of Anti-Cancer Drugs

Kaushiki Chatterjee
Sumit Mukherjee
Jonathan Vanmanen
Probal Banerjee
Jimmie E. Fata

Frontiers in Oncology

doi 10.3389/fonc.2019.00352

8,485 views
56 citations

Editorial

Published on 08 May 2019

Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors

in Pharmacology of Anti-Cancer Drugs

Bernardo Leon Rapoport

Frontiers in Oncology

doi 10.3389/fonc.2019.00365

2,784 views
3 citations

Original Research

Published on 07 May 2019

Down Regulation of the Expression of ELMO3 by COX2 Inhibitor Suppresses Tumor Growth and Metastasis in Non-Small-Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Cailong Pan
Yong Zhang
Qinghai Meng
Guoliang Dai
Zhitao Jiang
Hongguang Bao

Frontiers in Oncology

doi 10.3389/fonc.2019.00363

3,154 views
14 citations

Review

Published on 02 May 2019

NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance

in Pharmacology of Anti-Cancer Drugs

Antonio Lucena-Cacace
Masayuki Umeda
Lola E. Navas
Amancio Carnero

Frontiers in Oncology

doi 10.3389/fonc.2019.00292

10,813 views
34 citations

Mini Review

Published on 30 Apr 2019

Pre-clinical Models for Studying the Interaction Between Mesenchymal Stromal Cells and Cancer Cells and the Induction of Stemness

in Pharmacology of Anti-Cancer Drugs

Sofia Avnet
Silvia Lemma
Margherita Cortini
Gemma Di Pompo
Francesca Perut
Nicola Baldini

Frontiers in Oncology

doi 10.3389/fonc.2019.00305

5,784 views
26 citations

Original Research

Published on 26 Apr 2019

Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell Lines

in Pharmacology of Anti-Cancer Drugs

Saeed Nourmohammadi
Thazin Nwe Aung
Jian Cui
Jinxin V. Pei
Michael Lucio De Ieso
Yuka Harata-Lee
Zhipeng Qu
David L. Adelson
Andrea J. Yool

Frontiers in Oncology

doi 10.3389/fonc.2019.00314

8,376 views
47 citations

Original Research

Published on 26 Apr 2019

Inhibition of Murine Breast Cancer Metastases by Hydrophilic As4S4 Nanoparticles Is Associated With Decreased ROS and HIF-1α Downregulation

in Pharmacology of Anti-Cancer Drugs

Tao Wang
Jie Meng
Chuan Wang
Tao Wen
Mengfan Jia
Yangyang Ge
Lifei Xie
Suisui Hao
Jian Liu
Haiyan Xu

Frontiers in Oncology

doi 10.3389/fonc.2019.00333

5,273 views
28 citations

Original Research

Published on 10 Apr 2019

Inula Viscosa Extract Inhibits Growth of Colorectal Cancer Cells in vitro and in vivo Through Induction of Apoptosis

in Pharmacology of Anti-Cancer Drugs

Rinat Bar-Shalom
Margalit Bergman
Shlomo Grossman
Naiel Azzam
Lital Sharvit
Fuad Fares

Frontiers in Oncology

doi 10.3389/fonc.2019.00227

16,798 views
42 citations

Original Research

Published on 09 Apr 2019

MPT0G413, A Novel HDAC6-Selective Inhibitor, and Bortezomib Synergistically Exert Anti-tumor Activity in Multiple Myeloma Cells

in Pharmacology of Anti-Cancer Drugs

Fang-I Huang
Yi-Wen Wu
Ting-Yi Sung
Jing-Ping Liou
Mei-Hsiang Lin
Shiow-Lin Pan
Chia-Ron Yang

Frontiers in Oncology

doi 10.3389/fonc.2019.00249

5,842 views
22 citations

Original Research

Published on 03 Apr 2019

Antiproliferative Effects of the Natural Oxadiazine Nocuolin A Are Associated With Impairment of Mitochondrial Oxidative Phosphorylation

in Pharmacology of Anti-Cancer Drugs

Maria Lígia Sousa
Marco Preto
Vítor Vasconcelos
Stig Linder
Ralph Urbatzka

Frontiers in Oncology

doi 10.3389/fonc.2019.00224

5,165 views
17 citations

Original Research

Published on 03 Apr 2019

RETRACTED: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

in Pharmacology of Anti-Cancer Drugs

Hanbo Cao
Wenjun Li
Yizhou Zhou
Renxiang Tan
Yue Yang
You Zhou
Qinglong Guo
Li Zhao

Frontiers in Oncology

doi 10.3389/fonc.2019.00188

3,199 views
6 citations

Navigation group

Articles

The Efficacy of Different Chemotherapy Regimens for Advanced Biliary Tract Cancer: A Systematic Review and Network Meta-Analysis

Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia

Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas

Triptolide Induces Glioma Cell Autophagy and Apoptosis via Upregulating the ROS/JNK and Downregulating the Akt/mTOR Signaling Pathways

Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells

Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis

Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors

Down Regulation of the Expression of ELMO3 by COX2 Inhibitor Suppresses Tumor Growth and Metastasis in Non-Small-Cell Lung Cancer

NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance

Pre-clinical Models for Studying the Interaction Between Mesenchymal Stromal Cells and Cancer Cells and the Induction of Stemness

Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell Lines

Inhibition of Murine Breast Cancer Metastases by Hydrophilic As4S4 Nanoparticles Is Associated With Decreased ROS and HIF-1α Downregulation

Inula Viscosa Extract Inhibits Growth of Colorectal Cancer Cells in vitro and in vivo Through Induction of Apoptosis

MPT0G413, A Novel HDAC6-Selective Inhibitor, and Bortezomib Synergistically Exert Anti-tumor Activity in Multiple Myeloma Cells

Antiproliferative Effects of the Natural Oxadiazine Nocuolin A Are Associated With Impairment of Mitochondrial Oxidative Phosphorylation

RETRACTED: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway